SCHEMBL22964307

SCHEMBL22964307

OCCOc1cc(S)ccc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 2/20 0.40
CYP2C19 P33261 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
MAPK1 P28482 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TRPV1 Q8NER1 1/20 0.36
IDO1 P14902 1/20 0.36
TSHR P16473 2/20 0.36
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19440160 0.81 CSNK2A1 (0.47) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL10359297 0.81 ALDH1A1 (0.68) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL22596995 0.80 L3MBTL1 (0.50) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL21477276 0.79 ALDH1A1 (0.49) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL22714464 0.79 L3MBTL1 (0.45) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL10358917 0.78 MAPT (0.65) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL13184060 0.78 ALDH1A1 (0.47) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL11069560 0.78 ALDH1A1 (0.44) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL21465857 0.77 ALDH1A1 (0.45) ALDH1A1LMNANPSR1CYP2C19MEN1
SCHEMBL13672486 0.74 KDM4E (0.40) ALDH1A1MAPTKMT2AL3MBTL1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10961231-B2 NTCP inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-03-30 US disclosed
US-20210040072-A1 NTCP Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040072-A1 NTCP Inhibitors HAVCR2, NPC1, HMGCR ALDH1A1 4749/4885LMNA 3338/4885NPSR1 1396/4885
US-10961231-B2 NTCP inhibitors HAVCR2, NPC1, HMGCR ALDH1A1 4749/4885LMNA 3338/4885NPSR1 1396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.